Sabra Health Care REIT (SBRA) Tops Q4 EPS by 3c; offers guidance
Sabra Health Care REIT (NASDAQ: SBRA) reported Q4 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $182.35 million versus the consensus estimate of $177.38 million.
GUIDANCE:
Sabra Health Care REIT sees FY2025 EPS of $0.67-$0.70, versus the consensus of $0.71.
For earnings history and earnings-related data on Sabra Health Care REIT (SBRA) click here.
